Odontología
Faculty
Isabel
Lastres Becker
Publications by the researcher in collaboration with Isabel Lastres Becker (14)
2024
-
Gamificación en farmacología: Escape room virtual
III Jornada «Aprendizaje Eficaz con TIC en la UCM» (Ediciones Complutense), pp. 101-114
2005
-
Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice
Brain Research, Vol. 1046, Núm. 1-2, pp. 195-206
-
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
Neurobiology of Disease, Vol. 19, Núm. 1-2, pp. 96-107
2004
-
Involvement of the endocannabinoid system in motor disorders
Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Núm. 3, pp. 175-182
-
Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: In vivo and in vitro evidence
Brain Research, Vol. 1007, Núm. 1-2, pp. 152-159
2002
-
Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease
Synapse, Vol. 44, Núm. 1, pp. 23-35
-
Endocannabinoids and basal ganglia functionality
Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 66, Núm. 2-3, pp. 257-267
-
Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's disease
Neurotoxicity Research, Vol. 4, Núm. 7-8, pp. 601-608
-
Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease
Brain Research, Vol. 929, Núm. 2, pp. 236-242
-
The endogenous cannabinoid system and the basal ganglia: Biochemical, pharmacological, and therapeutic aspects
Pharmacology and Therapeutics, Vol. 95, Núm. 2, pp. 137-152
2001
-
Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease
NeuroReport, Vol. 12, Núm. 10, pp. 2125-2129
-
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors
Journal of Medicinal Chemistry, Vol. 44, Núm. 26, pp. 4505-4508
-
Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets
European Journal of Neuroscience, Vol. 14, Núm. 11, pp. 1827-1832
1999
-
Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide
Life Sciences, Vol. 65, Núm. 3, pp. 327-336